ACCESS: an empirically-based framework developed by the International Nursing CASCADE Consortium to address genomic disparities through the nursing workforce.

Autor: Katapodi MC; International Nursing CASCADE Consortium, Basel, Switzerland.; Department of Clinical Research, University of Basel, Basel, Switzerland., Pedrazzani C; International Nursing CASCADE Consortium, Basel, Switzerland.; Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland., Barnoy S; International Nursing CASCADE Consortium, Basel, Switzerland.; Nursing Department, Tel-Aviv University, Tel Aviv, Israel., Dagan E; International Nursing CASCADE Consortium, Basel, Switzerland.; The Cheryl Spencer Department of Nursing, University of Haifa, Haifa, Israel., Fluri M; International Nursing CASCADE Consortium, Basel, Switzerland.; Inselspital, Bern University Hospital, Bern, Switzerland., Jones T; International Nursing CASCADE Consortium, Basel, Switzerland.; Christine E. Lynn College of Nursing, Florida Atlantic University, Boca Raton, FL, United States., Kim S; International Nursing CASCADE Consortium, Basel, Switzerland.; College of Nursing, Yonsei University, Seoul, Republic of Korea., Underhill-Blazey ML; International Nursing CASCADE Consortium, Basel, Switzerland.; School of Nursing, University of Rochester, Rochester, NY, United States., Uveges MK; International Nursing CASCADE Consortium, Basel, Switzerland.; William F. Connell School of Nursing, Boston College, Boston, MA, United States., Dwyer AA; International Nursing CASCADE Consortium, Basel, Switzerland.; William F. Connell School of Nursing, Boston College, Boston, MA, United States.; Massachusetts General Hospital, Harvard Center for Reproductive Medicine, Boston, MA, United States.

Publikováno v: Frontiers in genetics [Front Genet] 2024 Jan 08; Vol. 14, pp. 1337366. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

How does patient-centered communication in ovarian cancer care enhance patient well-being? A mixed methods study.

Autor: Pozzar RA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: rachel_pozzar@dfci.harvard.edu., Xiong N; Dana-Farber Cancer Institute, Boston, MA, USA., Hong F; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Wright AA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Goff BA; University of Washington, Seattle, WA., Underhill-Blazey ML; University of Rochester, Rochester, NY, USA., Tulsky JA; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Hammer MJ; Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Berry DL; University of Washington, Seattle, WA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2022 Nov; Vol. 167 (2), pp. 261-268. Date of Electronic Publication: 2022 Aug 31.

Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.

Autor: Baroutsou V; Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland., Underhill-Blazey ML; School of Nursing, Wilmot Cancer Institute Hereditary Cancer Program, University of Rochester, Rochester, NY 14642, USA., Appenzeller-Herzog C; University Medical Library, University of Basel, 4051 Basel, Switzerland., Katapodi MC; Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2021 Feb 23; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 23.

Chemotherapy Education and Support: A Model for Use in the Ambulatory Care Setting.

Autor: Jabaley T; Dana-Farber Cancer Institute., Rizzo P; Dana-Farber Cancer Institute., Grenon NN; Dana-Farber Cancer Institute, Boston, MA., Sullivan C; Dana-Farber Cancer Institute., Bagley J; Dana-Farber Cancer Institute., Nassif M; Dana-Farber Cancer Institute., Siegel R; Dana-Farber Cancer Institute., Underhill-Blazey ML; Dana-Farber Cancer Institute.

Publikováno v: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2020 Aug 01; Vol. 24 (4), pp. E43-E49.

Development and Testing of a Decision Aid for Unaffected Women with a BRCA1 or BRCA2 Mutation.

Autor: Jabaley T; The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana Farber Cancer Institute, 375 Longwood Ave., Boston, MA, 02215, USA. theresa_jabaley@dfci.harvard.edu., Underhill-Blazey ML; The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Cancer Genetics and Prevention Program, Dana-Farber Cancer Institute, Boston, MA, USA., Berry DL; The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana Farber Cancer Institute, 375 Longwood Ave., Boston, MA, 02215, USA.

Publikováno v: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2020 Apr; Vol. 35 (2), pp. 339-344.